These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4951907)

  • 1. Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. II. Histopathology of lungs.
    Mayer E; Salamandra IA
    Am Rev Respir Dis; 1967 Aug; 96(2):220-8. PubMed ID: 4951907
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. I. Survival times of mice and course of the chronic disease; bacterial populations and responses of the host.
    Mayer E; Salamandra IA
    Am Rev Respir Dis; 1967 Aug; 96(2):209-19. PubMed ID: 5006454
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of the tuberculin response of rhesus monkeys by isoniazid therapy.
    Gibson JP; Rohovsky MW; Newberne JW
    Lab Anim Sci; 1971 Feb; 21(1):62-6. PubMed ID: 4322780
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of isoniazid on the early tuberculous lesions in the mouse].
    Mauss H
    Rev Immunol Ther Antimicrob; 1968; 32(6):357-74. PubMed ID: 4975681
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental tuberculosis with African strains of various drug-resistance.
    Zykov MP; Frank GL; Roulet H; Poti SJ
    Exp Pathol (Jena); 1972; 7(5):298-308. PubMed ID: 4660919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of combined therapy in patients with destructive tuberculosis of the lungs].
    Rzaĭ OV; Smyslov VV
    Probl Tuberk; 1979 Nov; (11):34-7. PubMed ID: 530966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Examining fibrotic process in lung during treatment of chronic murine tuberculosis with lysosomotropic drug isonaizid].
    Filimonov PN; Shkurupiĭ VA; Kurunov IuN; Pupyshev AB; Panasenko SG
    Probl Tuberk; 1999; (1):63-5. PubMed ID: 10199191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of isoniazid on the evolution of the pulmonary lesions in tuberculosis in mice].
    Mauss H
    Pathol Biol (Paris); 1971; 19(15):743-50. PubMed ID: 4942506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tubazid therapy of cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM; Klebanova AA; Novoselova VP
    Probl Tuberk; 1969; 47(1):77-83. PubMed ID: 5380215
    [No Abstract]   [Full Text] [Related]  

  • 12. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the use of the express intravenous administration of isoniazid to tuberculosis patients].
    Postoiuk MG
    Probl Tuberk; 1979 Jan; (1):68-9. PubMed ID: 419112
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with fast intravenous administration of isoniazid at antituberculous dispensaries].
    Khorosheva MN; Chernousova TIa
    Probl Tuberk; 1977 Aug; (8):35-8. PubMed ID: 905270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of chronic destructive tuberculosis of the lungs].
    Utkin VV
    Klin Med (Mosk); 1973 Mar; 51(3):83-9. PubMed ID: 4755487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rapid intravenous injections of an isoniazid solution in the combination treatment of pulmonary tuberculosis].
    Radzinskiĭ AG; Lisikhin VN
    Voen Med Zh; 1981 Mar; (3):34-6. PubMed ID: 7222489
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the granuloma in the experimental treatment of tuberculosis with a prolonged form of isoniazid].
    Shkurupiĭ VA; Chernova TG; Kurunov IuN
    Probl Tuberk; 1993; (1):38-41. PubMed ID: 7687054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous administration of antitubercular preparations in the complex treatment of patients with pulmonary tuberculosis associated with peptic ulcer].
    Mikhaĭlova ES; Vilenskaia RN; Kanevskaia SS
    Ter Arkh; 1974; 46(5):129-33. PubMed ID: 4428384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
    Bobarykin VS
    Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.